Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa

Nitric oxide (NO) is present in the human nasal airways and originates primarily from the paranasal sinuses. Immunohistochemical studies and messenger ribonucleic acid (mRNA) in situ hybridization indicate that a type-2 NO synthase (NOS) is constitutively expressed in healthy sinus epithelium. We have further characterized sinus NOS activity by studying the enzymatic conversion of L-arginine to L-citrulline in biopsies from sinus mucosa. Maxillary sinus biopsies were obtained from nine healthy subjects during reconstructive facial surgery. In addition, nasal NO concentrations in nine controls were compared with those found in five patients treated with high systemic doses of glucocorticosteroids. Finally, the effects of i.v. L-arginine infusion on nasal cavity NO concentrations were studied in six healthy subjects. Ca(2+)-independent NOS activity was found in all biopsies and was five times higher than Ca(2+)-dependent activity (179 +/- 64 and 36 +/- 17 pmol.g-1.min, respectively). There was no difference in nasal NO levels between controls (344 +/- 21 parts per billion (ppb)) and steroid-treated patients (342 +/- 36 ppb). Nasal NO levels increased up to 35% following i.v. infusion of L-arginine. We conclude that NOS activity in healthy sinus mucosa is predominantly Ca(2+)-independent and this NOS is not downregulated by systemic steroids. Furthermore, L-arginine infusion increases nasal airway NO excretion in vivo, indicating that the substrate concentration is a rate-limiting factor under basal conditions. These findings further support the notion that sinus NOS is identical or very closely related to the type-2 NOS; however, the regulation of expression seems to be fundamentally different from that described previously for this NOS isoform.

This article has been cited by other articles:

				ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930. [Full Text] [PDF]

				Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al. Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Eur. Respir. J., July 1, 2002; 20(1): 223 - 237. [Abstract] [Full Text] [PDF]

				D. C. Chambers, D. A. Carpenter, and J. G. Ayres Exchange dynamics of nitric oxide in the human nose J Appl Physiol, November 1, 2001; 91(5): 1924 - 1930. [Abstract] [Full Text] [PDF]

				Z. Lohinai, R. Stachlewitz, L. Virag, A.D. Szekely, G. Hasko, and C. Szabo Evidence for Reactive Nitrogen Species Formation in the Gingivomucosal Tissue Journal of Dental Research, February 1, 2001; 80(2): 470 - 475. [Abstract] [PDF]

				F. H. Guo, S. A. A. Comhair, S. Zheng, R. A. Dweik, N. T. Eissa, M. J. Thomassen, W. Calhoun, and S. C. Erzurum Molecular Mechanisms of Increased Nitric Oxide (NO) in Asthma: Evidence for Transcriptional and Post-Translational Regulation of NO Synthesis J. Immunol., June 1, 2000; 164(11): 5970 - 5980. [Abstract] [Full Text] [PDF]

				P. Silkoff Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2104 - 2117. [Full Text]

				W. E. Holden, J. P. Wilkins, M. Harris, H. A. Milczuk, and G. D. Giraud Temperature conditioning of nasal air: effects of vasoactive agents and involvement of nitric oxide J Appl Physiol, October 1, 1999; 87(4): 1260 - 1265. [Abstract] [Full Text] [PDF]

				J O N Lundberg and E Weitzberg Nasal nitric oxide in man Thorax, October 1, 1999; 54(10): 947 - 952. [Full Text]

				J. M. Chatkin, W. Qian, P. A. McClean, N. Zamel, J. Haight, and P. Silkoff Nitric Oxide Accumulation in the Nonventilated Nasal Cavity Arch Otolaryngol Head Neck Surg, June 1, 1999; 125(6): 682 - 685. [Abstract] [Full Text] [PDF]

				H. GRASEMANN and F. RATJEN Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 684 - 685. [Full Text] [PDF]

				L. J. V. Galietta, L. Musante, L. Romio, U. Caruso, A. Fantasia, A. Gazzolo, L. Romano, O. Sacco, G. A. Rossi, L. Varesio, et al. An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L917 - L923. [Abstract] [Full Text] [PDF]

				S. J. LINNANE, V. M. KEATINGS, C. M. COSTELLO, J. B. MOYNIHAN, C. M. O'CONNOR, M. X. FITZGERALD, and P. MCLOUGHLIN Total Sputum Nitrate plus Nitrite Is Raised during Acute Pulmonary Infection in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 207 - 212. [Abstract] [Full Text] [PDF]